A detailed history of Fmr LLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Fmr LLC holds 6,768,173 shares of XENE stock, worth $310 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
6,768,173
Previous 6,601,830 2.52%
Holding current value
$310 Million
Previous $284 Million 7.15%
% of portfolio
0.02%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$36.25 - $43.75 $6.03 Million - $7.28 Million
166,343 Added 2.52%
6,768,173 $264 Million
Q1 2024

May 13, 2024

BUY
$42.66 - $50.04 $40.4 Million - $47.3 Million
945,908 Added 16.72%
6,601,830 $284 Million
Q4 2023

Feb 13, 2024

BUY
$28.7 - $46.46 $40.3 Million - $65.2 Million
1,403,056 Added 32.99%
5,655,922 $261 Million
Q3 2023

Nov 13, 2023

SELL
$34.16 - $39.73 $32 Million - $37.2 Million
-935,841 Reduced 18.04%
4,252,866 $145 Million
Q2 2023

Aug 11, 2023

BUY
$34.84 - $43.54 $16.1 Million - $20.1 Million
460,858 Added 9.75%
5,188,707 $200 Million
Q1 2023

May 11, 2023

BUY
$33.46 - $40.35 $1.24 Million - $1.49 Million
37,020 Added 0.79%
4,727,849 $169 Million
Q4 2022

Feb 13, 2023

BUY
$33.06 - $39.43 $696,574 - $830,790
21,070 Added 0.45%
4,690,829 $185 Million
Q3 2022

Nov 10, 2022

BUY
$30.79 - $39.82 $3 Million - $3.88 Million
97,391 Added 2.13%
4,669,759 $169 Million
Q2 2022

Aug 12, 2022

BUY
$25.44 - $35.16 $18.8 Million - $26 Million
738,892 Added 19.27%
4,572,368 $139 Million
Q1 2022

May 13, 2022

SELL
$25.09 - $33.13 $1.92 Million - $2.54 Million
-76,541 Reduced 1.96%
3,833,476 $117 Million
Q4 2021

Feb 14, 2022

BUY
$15.6 - $35.4 $13.3 Million - $30.2 Million
853,261 Added 27.91%
3,910,017 $122 Million
Q3 2021

Nov 15, 2021

SELL
$14.86 - $19.45 $233,123 - $305,131
-15,688 Reduced 0.51%
3,056,756 $46.7 Million
Q2 2021

Aug 13, 2021

BUY
$16.81 - $20.0 $51.6 Million - $61.4 Million
3,072,444 New
3,072,444 $57.2 Million

Others Institutions Holding XENE

About Xenon Pharmaceuticals Inc.


  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.85B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.